Concepedia

Emmanuel Y. Mérigeon

EY

Statistics

Publications

6

Citations

268

H-Index

6

Active since

2006

Affiliations

University of Maryland, Baltimore(Current)

Gliknik (United States)

Pfizer (United States)

Emmanuel Y. Mérigeon is an author at University of Maryland, Baltimore specializing in life sciences, immunoglobulin function, and immunology.

Publications per year

2006–2019

6

Publications

6

Assay for Measurement of Intact B-Type Natriuretic Peptide Prohormone in Blood

Isabelle Giuliani, François Rieunier, Catherine Larue et al. · Clinical Chemistry · 2006 · 121 citations · Full text

, , +14

Fully recombinant IgG2a Fc multimers (stradomers) effectively treat collagen-induced arthritis and prevent idiopathic thrombocytopenic purpura in mice

Ajay Jain, Henrik S. Olsen, Ravi Vyzasatya et al. · Arthritis Research & Therapy · 2012 · 59 citations · Full text

, , +14

A fully recombinant human IgG1 Fc multimer (GL-2045) inhibits complement-mediated cytotoxicity and induces iC3b

Hua Zhou, Henrik S. Olsen, Edward So et al. · Blood Advances · 2017 · 30 citations · Full text

, , +7

A recombinant human IgG1 Fc multimer designed to mimic the active fraction of IVIG in autoimmunity

Xiaoyu Zhang, Jane Owens, Henrik S. Olsen et al. · JCI Insight · 2019 · 29 citations · Full text

, , +17

Recombinant human IgG1 based Fc multimers, with limited FcR binding capacity, can effectively inhibit complement-mediated disease

Haoping Sun, Henrik S. Olsen, Emmanuel Y. Mérigeon et al. · Journal of Autoimmunity · 2017 · 18 citations

, , +15

1–5 of 6